1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that offers laboratory medicine solutions. The company's products include amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents, in vitro transcribed RNA and plasmid DNA kits. It offers diagnostic products for use in clinical laboratories and bio/pharma partners’ diagnostic needs. The company distributes its products across Algeria, Australia, Austria, Belgium, Brazil, Bulgaria, Denmark, Egypt, Germany, Iceland, India, the UAE, the UK and the US, among others. Asuragen is headquartered in Austin, Texas, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.
Scope
Reasons to Buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.
Scope
- The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Asuragen Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides a detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Asuragen Inc Company Overview
Asuragen Inc Pipeline Products Overview
Asuragen Inc - Locations and Subsidiaries
Recent Developments
Appendix
List of Tables
Asuragen Inc, Key Employees
List of Figures
A selection of companies mentioned in this report includes:
- Verax Biomedical Inc
- Aviva Systems Biology Corp
- Abazyme LLC